Cargando…
Mechanism study of peptide GMBP1 and its receptor GRP78 in modulating gastric cancer MDR by iTRAQ-based proteomic analysis
BACKGROUND: Multidrug resistance (MDR) is a major obstacle to the treatment of gastric cancer (GC). Using a phage display approach, we previously obtained the peptide GMBP1, which specifically binds to the surface of MDR gastric cancer cells and is subsequently internalized. Furthermore, GMBP1 was s...
Autores principales: | Wang, Xiaojuan, Li, Yani, Xu, Guanghui, Liu, Muhan, Xue, Lin, Liu, Lijuan, Hu, Sijun, Zhang, Ying, Nie, Yongzhan, Liang, Shuhui, Wang, Biaoluo, Ding, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430905/ https://www.ncbi.nlm.nih.gov/pubmed/25943993 http://dx.doi.org/10.1186/s12885-015-1361-3 |
Ejemplares similares
-
iTRAQ-based proteomic analysis of duck muscle related to lipid oxidation
por: Zhang, Muhan, et al.
Publicado: (2021) -
GMBP1-conjugated manganese oxide nanoplates for in vivo monitoring of gastric cancer MDR using magnetic resonance imaging
por: Zhan, Wenhua, et al.
Publicado: (2020) -
i-Tracker: For quantitative proteomics using iTRAQ™
por: Shadforth, Ian P, et al.
Publicado: (2005) -
GRP78 in lung cancer
por: Xia, Shengkai, et al.
Publicado: (2021) -
iTRAQ-based quantitative proteomic analysis of salt stress in Spica Prunellae
por: Liu, Zixiu, et al.
Publicado: (2019)